Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma

Oncogene volume 25, pages 6959–6967 (2006)Cite this article

Abstract

Understanding how RhoC expression and activation are regulated is essential for deciphering its contribution to tumorigenesis. Here, we report that RhoC expression and activation are induced by the epithelial to mesenchymal transition (EMT) of colon carcinoma. Using LIM 1863 colon cancer cells, RhoC protein expression and subsequent activation were detected coincident with the loss of E-cadherin and acquisition of mesenchymal characteristics. Several Ets-1 binding sites were identified in the RhoC promoter, and evidence was obtained using chromatin immunoprecipitation that Ets-1 can regulate RhoC expression during the EMT. Interestingly, a marked decrease in RhoA activation associated with the EMT was observed that corresponds to the increase in RhoC expression. Use of shRNA established that RhoA inhibits and RhoC promotes post-EMT cell migration, demonstrating functional significance for their coordinate regulation. To assess the importance of RhoC expression in colon cancer, immunohistochemistry was performed on 566 colorectal tumors with known clinical outcome. The level of RhoC ranged from no expression to high expression, and statistical analysis revealed that elevated RhoC expression correlates with poor outcome as well as aberrant expression and localization of E-cadherin. These data provide one mechanism for how RhoC expression is regulated in colon carcinoma and substantiate its utility as a prognostic marker.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 3
Figure 2
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Alipov G, Nakayama T, Ito M, Kawai K, Naito S, Nakashima M et al. (2005). Histopathology 46: 202–208.

  • Bates RC, Bellovin DI, Brown C, Maynard E, Wu B, Kawakatsu H et al. (2005). J Clin Invest 115: 339–347.

  • Bates RC, Goldsmith JD, Bachelder RE, Brown C, Shibuya M, Oettgen P et al. (2003). Curr Biol 13: 1721–1727.

  • Bates RC, Mercurio AM . (2003). Mol Biol Cell 14: 1790–1800.

  • Bellovin DI, Bates RC, Muzikansky A, Rimm DL, Mercurio AM . (2005). Cancer Res 65: 10938–10945.

  • Bories JC, Willerford DM, Grevin D, Davidson L, Camus A, Martin P et al. (1995). Nature 377: 635–638.

  • Clark EA, Golub TR, Lander ES, Hynes RO . (2000). Nature 406: 532–535.

  • Dube A, Akbarali Y, Sato TN, Libermann TA, Oettgen P . (1999). Circ Res 84: 1177–1185.

  • Hakem A, Sanchez-Sweatman O, You-Ten A, Duncan G, Wakeham A, Khokha R et al. (2005). Genes Dev 19: 1974–1979.

  • Hu M, Shivdasani RA . (2005). Cancer Res 65: 8715–8722.

  • Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ et al. (2005). Cancer Cell 8: 197–209.

  • Ren XD, Schwartz MA . (2000). Methods Enzymol 325: 264–272.

  • Roy HK, Smyrk TC, Koetsier J, Victor TA, Wali RK . (2005). Dig Dis Sci 50: 42–46.

  • Sato Y . (1998). Hum Cell 11: 207–214.

  • Schwiebert LM, Mooney JL, Van Horn S, Gupta A, Schleimer RP . (1997). Am J Respir Cell Mol Biol 17: 106–113.

  • Shikada Y, Yoshino I, Okamoto T, Fukuyama S, Kameyama T, Maehara Y . (2003). Clin Cancer Res 9: 5282–5286.

  • Simpson KJ, Dugan AS, Mercurio AM . (2004). Cancer Res 64: 8694–8701.

  • Span PN, Manders P, Heuvel JJ, Thomas CM, Bosch RR, Beex LV et al. (2002). Oncogene 21: 8506–8509.

  • Tarin D, Thompson EW, Newgreen DF . (2005). Cancer Res 65: 5996–6000 ; discussion 6000–5991.

  • Thiery JP . (2002). Nat Rev Cancer 2: 442–454.

  • Thompson EW, Newgreen DF, Tarin D . (2005). Cancer Res 65: 5991–5995 ; discussion 5995.

  • Tootle TL, Rebay I . (2005). Bioessays 27: 285–298.

  • van Golen KL, Davies S, Wu ZF, Wang Y, Bucana CD, Root H et al. (1999). Clin Cancer Res 5: 2511–2519.

  • van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD . (2000). Cancer Res 60: 5832–5838.

  • Wang H, Li M, Rinehart JJ, Zhang R . (2004a). Clin Cancer Res 10: 1633–1644.

  • Wang W, Yang LY, Huang GW, Lu WQ, Yang ZL, Yang JQ et al. (2004b). Br J Cancer 90: 2349–2355.

  • Woods DB, Ghysdael J, Owen MJ . (1992). Nucleic Acids Res 20: 699–704.

  • Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C et al. (2004). Cell 117: 927–939.

Download references

Acknowledgements

This work was supported by NIH Grant CA107548 (AMM) and DOD Fellowships W81XWH-04-1-0339 (DIB) and W81XWH-04-1-0360 (KJS).

Author information

Author notes

  1. A M Mercurio

    Present address: Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA, 01605, USA

Authors and Affiliations

  1. Division of Cancer Biology and Angiogenesis, Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA

    D I Bellovin & A M Mercurio

  2. Department of Cell Biology, Harvard Medical School, Boston, MA, USA

    K J Simpson

  3. Division of Preventive Cardiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA

    T Danilov, E Maynard & P Oettgen

  4. Department of Pathology, Yale University Medical School, New Haven, CT, USA

    D L Rimm

Authors
  1. D I Bellovin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K J Simpson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T Danilov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E Maynard
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D L Rimm
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P Oettgen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A M Mercurio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A M Mercurio.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bellovin, D., Simpson, K., Danilov, T. et al. Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma. Oncogene 25, 6959–6967 (2006). https://doi.org/10.1038/sj.onc.1209682

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209682

Keywords

This article is cited by

Search

Advanced search

Quick links